ALD

Poxel, winner of the 2023 edition of the I-nov contest

Retrieved on: 
Wednesday, July 5, 2023
Biotechnology, Pharmaceutical, Health, Clinical Trials, AMN, Male, State, Ministry of Culture (Spain), NASH, Adrenoleukodystrophy, Life, Marketing, Sovereignty, ALD, DSM-IV codes, Energy transition, Ministry, Ministry of Ecological Transition (France), Patient, Fatty liver disease, Marshal of France, Estonia, Investment, Ministry of Territorial Cohesion, Education, Ministry of Higher Education, Science, Research and Innovation, SME, Pharmaceutical industry, Renewable energy, Euronext, Culture, Research

This distinction is a recognition of the potential of the Company's drug candidates in development for this indication, PXL770 and PXL065.

Key Points: 
  • This distinction is a recognition of the potential of the Company's drug candidates in development for this indication, PXL770 and PXL065.
  • These studies are ready to be launched in adult male patients with adrenomyeloneuropathy (AMN), the most common form of ALD, subject to additional funding, which the Company is currently working on.
  • It selects, within the framework of a procedure encouraging competition, innovative projects with particularly high potential for the French economy.
  • The i-Nov competition, funded by the French State via France 2030 plan, is operated by Bpifrance in collaboration with ADEME.

Forge Nano Invests in the Future Workforce of Colorado as Partner of the Arrupe Jesuit High School Work Study Program

Retrieved on: 
Tuesday, June 27, 2023
Taste, Learning, Idol Drama Operation Team, Autumn, Arrupe Jesuit High School, Life, ALD, University, Science, Chemistry, Student, Energy storage, Engineering, STEM, Textbook, PH, Environment, Denver, Calibration, Management, Forge

DENVER, June 27, 2023 (GLOBE NEWSWIRE) -- Bolstering its commitment to a diverse and equal opportunity workforce, Forge Nano, Inc. – a global leader in surface engineering and precision nano-coating technology – has entered its second year as an industrial partner of the Arrupe Jesuit High School Work Study Program .

Key Points: 
  • DENVER, June 27, 2023 (GLOBE NEWSWIRE) -- Bolstering its commitment to a diverse and equal opportunity workforce, Forge Nano, Inc. – a global leader in surface engineering and precision nano-coating technology – has entered its second year as an industrial partner of the Arrupe Jesuit High School Work Study Program .
  • Hailed as an integral part of an Arrupe Jesuit education, the program provides opportunities for economically disadvantaged students to gain college-prep education through work experiences in entry-level corporate positions in the Denver Metro area.
  • As an industrial program partner, Forge Nano provides career mentoring and student tuition, giving students of all backgrounds the opportunity to gain highly sought-after skills.
  • With the goal of fostering an inclusive STEM program, Forge Nano first partnered with the Arrupe Jesuit High School in the Fall of 2022.

Medtech: BrainTale Gathers €4.5 Million to Accelerate the Development of Its Solution for Diagnosis, Monitoring and Prediction of Neurological Disorders

Retrieved on: 
Tuesday, June 20, 2023
Medical Devices, Health, Neurology, Health Technology, Pharmaceutical, Biotechnology, Drug development, Adrenoleukodystrophy, Professor, ALD, ESPCI, Hospital, Medical physics, Ageing, DSM-IV codes, Software, Multimedia, Brain, Engineer, Biomarker, Doctor of Philosophy, Harvard University, Intensivist, MRI, Alzheimer's disease, Parkinson's disease, Magnetic resonance imaging, Neuroscience, Patient, Myenteric plexus, Physician, Coma, Observation, White matter, Diagnosis, ALS, Pharmaceutical industry, Medical imaging, Software as a service, Neuroradiology, Atlantic Ocean

To explore this new continent of the brain, BrainTale is developing a measurement solution that improves diagnosis, monitoring and prediction with a non-invasive, pain-free, efficient and clinically validated approach.

Key Points: 
  • To explore this new continent of the brain, BrainTale is developing a measurement solution that improves diagnosis, monitoring and prediction with a non-invasive, pain-free, efficient and clinically validated approach.
  • "This fundraising is a decisive step for BrainTale, and enables us to look forward with ambition to our next development milestones.
  • BrainTale improves the practice of healthcare professionals and the quality of care by improving the prediction of neurological diseases such as Alzheimer's and Parkinson's diseases.
  • This round of financing will enable BrainTale to enter a new phase in its development," states Sébastien Couvet, head of the MACSF Group's e-health portfolio.

Archer achieves qubit material functionality at room temperature in air

Retrieved on: 
Tuesday, June 20, 2023
Vacuum, Semiconductor, Atmosphere, ALD, ASX, AXE, Research, Temperature, Carbon, Plasma, Architecture, PECVD, Electronics, Video game, Archery

SYDNEY, Australia, June 19, 2023 (GLOBE NEWSWIRE) -- Archer Materials Limited (“Archer”, the “Company”, “ASX: AXE”), a semiconductor company that advances the quantum computing and medical diagnostics industries, has achieved a significant development milestone in the functionality of its cutting-edge qubit material.

Key Points: 
  • Archer Materials has engineered its qubit material to mimic a high vacuum environment, preserving quantum functionality at room temperature in air.
  • The preservation of quantum coherence in Archer’s qubit material at room temperature in air demonstrates a significant advantage over qubit proposals that are difficult to integrate onboard modern day devices.
  • The Archer team has now for the first time preserved the qubit materials’ quantum coherence times and properties1 at room temperature in air while maintaining the intrinsic metallic-like character of the qubit material2.
  • “Archer has now demonstrated its qubit materials’ quantum coherence times observed at room temperature can be achieved under normal conditions, in air.

Poxel Announces its Participation at Patient Association Conferences in Adrenoleukodystrophy

Retrieved on: 
Thursday, June 15, 2023
Biotechnology, Health, Genetics, Pharmaceutical, Clinical Trials, AMN, Male, ULF, NASH, Adrenoleukodystrophy, ALD, Scientific communication, DSM-IV codes, Patient, Fatty liver disease, Leukodystrophy, R, POC, Pharmacology, Conference, TZD, Pharmaceutical industry, Euronext

Poxel remains committed to discover, develop, and commercialize innovative therapies for patients suffering from serious chronic and rare diseases with underlying metabolic pathophysiology, starting with ALD.

Key Points: 
  • Poxel remains committed to discover, develop, and commercialize innovative therapies for patients suffering from serious chronic and rare diseases with underlying metabolic pathophysiology, starting with ALD.
  • PXL770 and PXL065 have demonstrated preclinically their efficacy in adrenomyeloneuropathy (AMN) and cerebral ALD (c-ALD) in mouse and human models1.
  • In line with his mission to bring therapeutic options to treat ALD, Poxel recently supported the Alex Leukodystrophy Charity during their Community Weekend, which took place from April 28th to May 1st in Birmingham, England.
  • This event brings together leukodystrophy sufferers and their families, alongside doctors, researchers and scientists from around the world to discuss leukodystrophies.

Poxel Reports Cash and Revenue for the First Quarter 2023 and Provides Corporate Update

Retrieved on: 
Wednesday, May 17, 2023
Biotechnology, Pharmaceutical, Health, Clinical Trials, Adrenoleukodystrophy, Prescription, Imeglimin, Adenosine, Plasma, Journal, JPY, Patient, Serono, Merck, POC, Sumitomo Group, Disease, Male, Business development, FY, Pharmacokinetics, Autosomal dominant polycystic kidney disease, American Association for the Study of Liver Diseases, USD, European Commission, Polycystic kidney disease, Kidney International, HIV disease progression rates, Fatty liver disease, ADPKD, FDA, IPF, Safety, Abstract, DPP4, ALD, ODD, JDS, Merck Serono, Biomarker, DSM-IV codes, AMN, Non-U.S. operators of the M60 Patton, IRIS, Sumitomo Pharma, SGLT2, VLCFA, Life Sciences (journal), Regulation of tobacco by the U.S. Food and Drug Administration, Food, Autosome, Pharmaceutical industry, Bank, Management, EUR, Euronext

POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare metabolic disorders, today provided a corporate update and announced its cash position and revenue for the first quarter ended March 31, 2023.

Key Points: 
  • POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare metabolic disorders, today provided a corporate update and announced its cash position and revenue for the first quarter ended March 31, 2023.
  • Thomas Kuhn, Chief Executive Officer of Poxel, stated: “This quarter we successfully restructured our debt obligations and increased our financial flexibility with a new equity-linked financing with IRIS.
  • For the Sumitomo FY 2023, as a conservative assumption in line with Sumitomo’s forecast, Poxel expects to receive 8% royalties on TWYMEEG net sales.
  • As of March 31, 2023, cash and cash equivalents were EUR 10.6 million (USD 11.6 million), as compared to EUR 13.1 million (USD 14.0 million) as of December 31, 2022.

Society for Information Display Unveils 2023 Display Industry Award Winners

Retrieved on: 
Monday, May 15, 2023
Cloud, Society for Information Display, Digital cinema, TFE, Society, MicroLED, XY, ALD, Ã, LTPS, Display, 3D, PRO, Electronics, TFT, SID, Q-D-Š, USB On-The-Go, VGA, LCD, Smartglasses, Creativity, Quantum dot, HALOT, International Symposium on Symbolic and Algebraic Computation, Creality, OLED, QD-OLED, Virtual reality, BOE, Silicon, RGB, DIA, Quantum, Samsung Display, AR, Head-up display, Motorcycle, Television, Entertainment, Exhibition

CAMPBELL, Calif., May 15, 2023 /PRNewswire/ -- The Society for Information Display (SID) is pleased to announce the winners of its 29th Annual Display Industry Awards. The 2023 Display Industry Award (DIA) recipients reflect the ever-evolving display and imaging product landscape and represent a wide range of technological advancements with products designed to make devices that are more sustainable, economical, and engaging while providing users with a more dynamic visual experience. The honorees will be recognized and receive their awards in conjunction with SID's annual Display Week, being held in Los Angeles, California, May 21-26, 2023. Now in its 60th year, SID's annual International Symposium, Seminar and Exhibition (known as "Display Week") is the premier event for the global electronic display and visual information technology industries.

Key Points: 
  • CAMPBELL, Calif., May 15, 2023 /PRNewswire/ -- The Society for Information Display (SID) is pleased to announce the winners of its 29th Annual Display Industry Awards.
  • "The 2023 Display Industry Award winners reflect the very best the display industry has to offer," says Stephen Atwood, acting chair of the DIA Committee .
  • A more comprehensive description of the award winners is included in the Display Week 2023 Show Issue of Information Display magazine or at www.informationdisplay.org .
  • To be considered for a 2023 Display Industry Award, a product had to be available for purchase during the 2022 calendar year.

ALD: Trading update on Q1 2023 results

Retrieved on: 
Friday, May 12, 2023
Partnership, EV, Bank, Service, Bank statement, ALD, VS, NET, Carbon, USD, ChargePoint, Sale, EVS, EUR, Asset, Acquisition, UNIT, Regulatory News Service, Depreciation, Growth, UCS, Total, Security (finance), Lithium, Jet fuel, Renting, Satellite navigation device, Road, Video game, Mobile phone, Film industry, Risk, EU, LeasePlan

ALD recorded a sharp increase in financial results in Q1 2023, driven by high margin growth and continued high Used car sales results.

Key Points: 
  • ALD recorded a sharp increase in financial results in Q1 2023, driven by high margin growth and continued high Used car sales results.
  • Leasing contract margin reached EUR 366.6 million in Q1 2023, vs. EUR 171.4 million in Q1 2022, up 80.7% excluding non-operating items.
  • UCS result per unit [14] came in at EUR 2,535 in Q1 2023 vs. EUR 3,101 in Q1 2022.
  • ALD’s Net Income (Group Share) reached EUR 315.5 million in Q1 2023, up 22.4% from EUR 257.7 million in Q1 2022.

Unveiling the Future of Vaping: Highlights from the FRESOR Launch Event

Retrieved on: 
Friday, May 5, 2023
Tobacco, Retail, Specialty, Cloud, ALD, Multimedia, Waterfall, Electric motor

ALD hosted a highly anticipated online brand launch event on YouTube to announce its original technology brand, FRESOR.

Key Points: 
  • ALD hosted a highly anticipated online brand launch event on YouTube to announce its original technology brand, FRESOR.
  • The FRESOR team unveiled 2 major technology platforms: FRESOR NOVA and FRESOR MAX, which represent cutting-edge advancements in the vaping industry.
  • The FRESOR brand launch event was a huge success and filled with excitement as the ALD team walked attendees through the origins, features and benefits of FRESOR.
  • Visitors to the FRESOR booth (C90) can experience the latest vaping firsthand and learn further about what FRESOR has in store.

Forge Nano Partners with Aleon Renewable Metals for Battery Recycling and Supply of Materials for EV Batteries

Retrieved on: 
Tuesday, May 2, 2023
Partnership, EV, Lithium, ALD, ARM, CAM, Recycling, Particle, Nickel, Engineering, MPSC, Ecosystem, Atomic layer deposition, Cobalt, Environment, Metal, Electric battery

DENVER, May 2, 2023 /PRNewswire/ -- Forge Nano, a global leader in surface engineering and precision nano-coating technology, and Aleon Renewable Metals (ARM), an integrated lithium-ion battery recycler, announced a partnership today for battery recycling and supply of battery materials.

Key Points: 
  • DENVER, May 2, 2023 /PRNewswire/ -- Forge Nano, a global leader in surface engineering and precision nano-coating technology, and Aleon Renewable Metals (ARM), an integrated lithium-ion battery recycler, announced a partnership today for battery recycling and supply of battery materials.
  • Aleon Renewable Metals will recycle Forge Nano's battery scrap at its industry-leading battery recycling facilities in Texas and Oklahoma utilizing Forge Nano's technology to manufacture cathode active materials (CAM) from the battery grade materials produced by ARM.
  • Batteries made with Atomic Armor are optimized to be longer-lasting and safer than current batteries on the market.
  • Aleon Renewable Metals leverages our proprietary recycling technologies to support the global transition to circular supply chains and cleaner energy.